Andrea Gombos

5PUBLICATIONS
56CO-AUTHORS
Molecular targetsPsychosocial aspects of childbirth and perinatal mental healthCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 10, 2026
EVERolimus effectiveness after proGREssion on ENdocrine therapy plus CDK4/6 inhibitor for ER-positive/HER2-negative advanced breast cancer: EVERGREEN study.

|Jul 09, 2025
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial.

Fedro A Peccatori, Samuel M Niman, Ann H Partridge

|Mar 17, 2022
Author Correction: FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Andrea Gombos, David Venet, Lieveke Ameye

|Sep 22, 2021
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer.

Andrea Gombos, David Venet, Lieveke Ameye

|Jun 25, 2019
Investigational drugs in early stage clinical trials for the treatment of HER2+ breast cancer.

Andrea Gombos, Maria Alice Franzoi, Ahmad Awada

Pageof 1

Frequent Collaborators

3 joint publications

Francois P Duhoux

2 joint publications

Christos Sotiriou

2 joint publications

Thomas Guiot

2 joint publications

Michail Ignatiadis